Rachel Walsh

Rachel Walsh is currently the Senior Manager of Clinical and Scientific Affairs at Tiger Aesthetics, a position held since March 2024 following the acquisition of Revelle Aesthetics in November 2024. Prior to this role, Rachel served as the Senior Manager and Manager of Clinical Affairs at Revelle Aesthetics from September 2020 to March 2024. Rachel’s extensive experience at NeoTract from August 2011 to September 2020 included roles such as Clinical Trial Manager, Clinical Operations Lead, and Clinical Research Associate. Significant contributions included developing training programs, overseeing post-market clinical studies, managing data lock processes, and ensuring compliance with regulations. Early in Rachel’s career, experience as a Quality Systems Analyst and a News Intern at KQED enriched professional expertise. Rachel holds a Bachelor of Arts from San Francisco State University and a Certification in Clinical Trials Design and Management from the same institution.